265
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Edaravone attenuates myocyte apoptosis through the JAK2/STAT3 pathway in acute myocardial infarction

, , , &
Pages 351-359 | Received 30 Oct 2019, Accepted 12 May 2020, Published online: 16 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Difei Gong, Tianyi Yuan, Ranran Wang, Shuchan Sun, Awaguli Dawuti, Shoubao Wang, Guanhua Du & Lianhua Fang. (2023) Network pharmacology approach and experimental verification of Dan-Shen Decoction in the treatment of ischemic heart disease. Pharmaceutical Biology 61:1, pages 69-79.
Read now
Shuo Wang, Yuying Liu, Xitian Hu, Xiaolei Zhang, Lei Xu, Yan Yang, Rubing Wu, Enmao Wang & Tianjie Lv. (2021) Identification of ceRNA (lncRNA-miRNA-mRNA) Regulatory Network in Myocardial Fibrosis After Acute Myocardial Infarction. International Journal of General Medicine 14, pages 9977-9990.
Read now

Articles from other publishers (10)

Jerome Ndudi Asiwe, Benneth Ben-Azu, Godwin D. Yovwin, Santos Ehizokhale Ehebha, Vincent-Junior Onoriode Igben, Endurance Efe Ahama, Akpevwoghene Agbatutu, Tarela Melish Elias Daubry, Benjamin Oritsemuelebi & Emuesiri Goodies Moke. (2023) Enhancements of Bcl-2/mTOR/ERK1/2 activities by antioxidant mechanisms confer cardioprotection on Ginkgo biloba supplement against isoprenaline-induced myocardial infarction in rats. Pharmacological Research - Modern Chinese Medicine 8, pages 100293.
Crossref
Hongdan Wang, Bingyu Zhang, Xianhua Zhong, Dui Qin & Zhangyong Li. (2023) Mechanism Research of Platelet Core Marker Prediction and Molecular Recognition in Cardiovascular Events. Combinatorial Chemistry & High Throughput Screening 26:1, pages 103-115.
Crossref
Zhenbo Su, Siyao Liu, Yinggang Zou, Liang Shan, Miao Yu, Shishun Xie, Xiangjun Li & Ying Jin. (2023) Trastuzumab-induced human cardiomyocyte damage through the Notch2/JAK2/STAT3 pathway. Clinics 78, pages 100268.
Crossref
Li Xiao, Xue Li, Peilin Cao, Wei Fei, Hao Zhou, Na Tang & Yi Liu. (2022) Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Sina Mahdiani, Navid Omidkhoda, Ramin Rezaee, Shadi Heidari & Gholamreza Karimi. (2022) Induction of JAK2/STAT3 pathway contributes to protective effects of different therapeutics against myocardial ischemia/reperfusion. Biomedicine & Pharmacotherapy 155, pages 113751.
Crossref
Jianping Liu, Xunhong Duan, Rong Ye, Junqi Xiao, Cuifu Fang & Fengen Liu. (2022) Deep Learning Reconstruction Algorithm-Based MRI Image Evaluation of Edaravone in the Treatment of Lower Limb Ischemia-Reperfusion Injury. Contrast Media & Molecular Imaging 2022, pages 1-10.
Crossref
Haruhito A. Uchida, Tetsuharu Takatsuka, Yoshiko Hada, Ryoko Umebayashi, Hidemi Takeuchi, Kenichi Shikata, Venkateswaran Subramanian, Alan Daugherty & Jun Wada. (2022) Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. Biomolecules 12:8, pages 1117.
Crossref
V.M. Zhebel & O.L. Strazhynska. (2022) Нові можливості застосування блокатора ішемічного каскаду в терапії гострого інфаркту міокарда. EMERGENCY MEDICINE 18:1, pages 35-41.
Crossref
Haidong Guo, Runfang Yang, Jin He, Ke Chen, Wen Yang, Junjun Liu, Kai Xiao & Hongxia Li. (2021) Edaravone combined with dexamethasone exhibits synergic effects on attenuating smoke-induced inhalation lung injury in rats. Biomedicine & Pharmacotherapy 141, pages 111894.
Crossref
Suoli Cheng, Jianping Zheng, Xueqin Liu, Jiandang Shi, Fan Gong, Xu Zhang, Changhao Liu & Cuiyun Liu. (2021) Knockdown of 91 H Suppresses the Tumorigenesis of Osteosarcoma via Inducing Methylation of CDK4 Promoter. Technology in Cancer Research & Treatment 20, pages 153303382199000.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.